Cell Lysis & Disruption Market Trends

Cell Lysis & Disruption Market Trends

• As the pharmaceutical industry continues to witness unprecedented growth in the development of biologically derived drugs, the demand for efficient cell lysis and disruption technologies is expected to escalate. These techniques are integral in extracting valuable cellular components, such as proteins, enzymes, and nucleic acids, to produce biopharmaceuticals. Thus, surge in biopharmaceutical research has emerged as a potent catalyst propelling the cell lysis and disruption market forward.
   
• Further, the continuous expansion of biologics and personalized medicine has increased the demand for innovative and high-throughput cell lysis methods to facilitate the isolation of target biomolecules. For instance, in 2014, personalized medicines accounted for only 21% of the total FDA approved new molecular entities, while in 2022 they accounted for 34% of approved new molecular entities.
   
• Thus, the demand for precise and efficient cell lysis methods has surged, driven by the need to obtain high-quality biomolecules for personalized diagnostics, drug development, and therapy monitoring.
   

However, the acquisition and maintenance costs associated with cutting-edge cell lysis equipment may be prohibitive for many laboratories and organizations, particularly those with limited budgets. This factor of high costs may pose a challenge for market growth.